Skip to content
Government Federal, Medical Health Aged Care

New grants support innovation in cancer research

Cancer Australia 3 mins read

The Minister for Health and Aged Care, the Hon Mark Butler MP today announced over $5.7 million in funding through Cancer Australia’sPriority-driven Collaborative Cancer Research Scheme (PdCCRS) aimed at driving innovative cancer research initiatives.

The 15 grants, supported by $3.61 million from the Australian Government through Cancer Australia and $2.17 million from Cancer Australia’s Funding Partners, mark a valuable investment in advancing cancer research across a diverse spectrum of cancer types, including lung, prostate, brain, colorectal, breast, ovarian, and blood cancers.

The grants address different population groups, including children, underscoring the importance of improving outcomes for cancer across all demographics, aligning with the Australian Cancer Plan and its focus on equity.

The research types supported include translational research, which focuses on translating scientific discoveries into clinical applications, as well as health services research aimed at improving healthcare delivery and patient outcomes.

Since 2007, Cancer Australia and its Funding Partners have supported 485 cancer research projects in key priority areas through the PdCCRS and international partnerships, with a total value of more than $170 million. Partnerships in delivering priority research are key to achieving the goals and ambitions of the Australian Cancer Plan.

Funding Partners contributing to this year’s grants include the Australian Lions Childhood Cancer Research Foundation, Bowel Cancer Australia, Can Too Foundation, Leukaemia Foundation, Lung Foundation Australia, My Room Children’s Cancer Charity Limited, Ovarian Cancer Research Foundation, and The Kids’ Cancer Project. These organisations demonstrate their unwavering commitment to advancing cancer research and improving outcomes for individuals affected by cancer with this financial support.

Successful applicants and their projects are:  

·        Dr Sarah Boyle, Centre for Cancer Biology (University of South Australia and SA Pathology) Tackling breast cancer growth and metastasis by suppressing ROCK-regulated paracrine signalling

·        Dr Hilary Byrne, University of Sydney How are you breathing today?

·        Dr Alexander Cole, Centenary Institute Treating chemoresistant ovarian cancer: Blocking follistatin signalling to enhance the effects of chemotherapy and prevent recurrence of chemoresistant disease

·        Professor Richard D'Andrea, University of South Australia Integrating cancer germline genetics, precision medicine and oncology to optimise management of paediatric AML

·        Professor Matt Dun, The University of Newcastle Taming free radicals to silence the epigenome of kinase active paediatric cancers

·        Dr Nicholas Hindley, University of Sydney From relativity to respiration: How ideas from Einstein’s general theory enable adaptative radiation therapy for lung cancer patients

·        Associate Professor Michelle McDonald, University of Sydney The Skeleton: A Reservoir for Metastatic Outgrowth

·        Professor Michael Samuel, University of South Australia Insights from the functional tumour secretome: new opportunities to monitor and halt colorectal cancer progression

·        Associate Professor Elaine Sanij, St Vincent's Institute of Medical Research Harnessing the nucleolar stress response in cancer therapy

·        Dr Oliver Schumacher, Edith Cowan University Exercise as a novel therapeutic approach for sensitising prostate cancer to radiotherapy

·        Associate Professor Luke Selth, Flinders University A novel hormonal therapy to treat lethal prostate cancer

·        Associate Professor Kate Sutherland, The Walter and Eliza Hall Institute of Medical Research Exploiting cell-of-origin features to improve treatment for KEAP1-mutant lung cancer

·        Dr Paniz Tavakoli Shirazi, The Council of the Queensland Institute of Medical Research Effect of co-occurring mutations on therapy response and resistance

·        Dr Lauren Thurgood, Flinders UniversityNon-canonical PI3K targeting - novel therapies to exploit the lipid dependency of CLL

·        Dr Kate Vandyke, The University of AdelaidePriming the blood-brain barrier to improve drug delivery and treatment outcomes in diffuse midline glioma

The PdCCRS is an annual national research grants scheme conducted by Cancer Australia in collaboration with the National Health and Medical Research Council (NHMRC).

For more information, please visit www.canceraustralia.gov.au  

Quotes attributable to Minister for Health and Aged Care, the Hon Mark Butler MP

"The PdCCRS grants unveiled today showcase the Government's dedication to funding high priority cancer research, aiming to enhance the well-being of all Australians impacted by cancer.”

"We are thrilled to support these pioneering research projects that hold the potential to make substantial contributions to cancer prevention, detection, treatment, and care.”

“We value our funding partners and their contributions, who, along with the government, recognise and champion the pivotal role of cancer research in improving patient outcomes."

“Supporting these projects aligns with the ambition of the Australian Cancer Plan - to achieve world-class cancer outcomes for all Australians - no matter who they are or where they live.”

Quotes attributable to Cancer Australia CEO Professor Dorothy Keefe

"Cancer knows no boundaries, and neither does our determination to improve outcomes for people affected by cancer."

"Through collaborative efforts and strategic investments in research, we can make significant strides towards a future where cancer is no longer a devastating diagnosis."

"This funding and these important partnerships underscore our commitment to accelerating progress in the field of cancer management and care across the continuum and together bringing hope to individuals and families affected by cancer."

 

 


Key Facts:

https://www.canceraustralia.gov.au/research/priority-driven-research


About us:

Cancer Australia was established by the Australian Government in 2006 to benefit all Australians affected by all cancers, and their families and carers. Cancer Australia aims to reduce the impact of cancer, address disparities and improve outcomes for people affected by cancer by leading and coordinating national, evidence-based interventions across the continuum of care. www.canceraustralia.gov.au @canceraustralia

More from this category

  • CharitiesAidWelfare, Medical Health Aged Care
  • 19/04/2024
  • 06:00
Leukaemia Foundation

Hon. Anna Bligh AC Joins Leukaemia Foundation as National Ambassador: A Decade in Remission from Blood Cancer

The Leukaemia Foundation today unveiled a powerful addition to its team of Ambassadors, the Honourable Anna Bligh AC. As the former Premier of Queensland…

  • Contains:
  • Community, Medical Health Aged Care
  • 18/04/2024
  • 22:00
Hepatitis NSW

Hepatitis NSW supports World Liver Day with launch of new website highlighting liver health

Hepatitis NSW has joined the worldwide movement to celebrate World Liver Day on Friday, 19 April 2024. World Liver Day aims to raise awareness about the importance of liver health. The liver is one of the most important organs in your body and is also one of the largest. The liver is an essential organ that performs over 500 functions, in doing so it supports the stomach, the heart and the blood. Specifically, it cleans blood, breaks down food, stores energy and vitamins, sends energy and vitamins to the parts of the body where it is all needed, clots the…

  • CharitiesAidWelfare, Medical Health Aged Care
  • 18/04/2024
  • 15:08
Leukaemia Foundation

The biggest challenge of cancer patients that nobody talks about… How the Leukaemia Foundation is combatting cancer related fatigue

It’s the number one challenge of people with cancer in Australia[i], yet ‘cancer related fatigue’ is the often-unspoken side effect that drains and debilitates thousands of Australians every day. With approximately one in two cancer patients reportedly experiencing moderate to severe fatigue during treatment[ii], and for many in the years following, the Leukaemia Foundation believes the prevalence of cancer related fatigue could be much higher. According to CEO, Chris Tanti, with the incidence of blood cancer continuing to soar (by 47% in the last decade[iii]), this means at least 70,000 Australians living with the disease are facing a daily battle…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.